Published in Nat Cell Biol on October 26, 2014
The Mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol (2015) 1.97
MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis. Cell Stem Cell (2016) 1.54
The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer (2016) 1.00
Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol (2015) 0.98
Targeting cell cycle regulators in hematologic malignancies. Front Cell Dev Biol (2015) 0.92
Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases. Elife (2016) 0.87
Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer. Curr Cancer Drug Targets (2015) 0.86
Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells. ACS Med Chem Lett (2016) 0.85
The role of Notch receptors in transcriptional regulation. J Cell Physiol (2015) 0.81
Phosphorylation-dependent regulation of Notch1 signaling: the fulcrum of Notch1 signaling. BMB Rep (2015) 0.78
Cyclin C surprises in tumour suppression. Nat Cell Biol (2014) 0.76
CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia. Leukemia (2015) 0.76
Oncogenic Notch signaling in T-cell and B-cell lymphoproliferative disorders. Curr Opin Hematol (2016) 0.75
A kinase-independent role for CDK19 in p53 response. Mol Cell Biol (2017) 0.75
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8. ACS Med Chem Lett (2016) 0.75
There will be blood: hematopoiesis control by mediator subunit MED12. Stem Cell Investig (2017) 0.75
Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. Nat Chem Biol (2017) 0.75
TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling. Int J Mol Sci (2017) 0.75
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
Inducible gene targeting in mice. Science (1995) 21.22
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (2004) 18.84
The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88
Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet (1999) 11.79
Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer (2009) 11.25
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer (2008) 7.93
Notch1 functions as a tumor suppressor in mouse skin. Nat Genet (2003) 6.76
Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell (1991) 6.65
CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature (2008) 6.24
A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature (1995) 4.93
Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes Dev (2001) 4.91
Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell (2009) 4.81
Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol Cell (1998) 4.09
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med (2007) 4.04
Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell (2004) 3.85
A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature (1996) 3.50
E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature (2008) 3.24
The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A (1991) 3.12
Activating Notch1 mutations in mouse models of T-ALL. Blood (2005) 3.08
CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol Cell (2007) 2.88
TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature (2000) 2.76
Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest (2008) 2.73
CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat Struct Mol Biol (2010) 2.70
The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. Genes Dev (2009) 2.69
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell (2013) 2.24
An evolutionarily conserved cyclin homolog from Drosophila rescues yeast deficient in G1 cyclins. Cell (1991) 2.19
Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. Proc Natl Acad Sci U S A (2013) 1.97
Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase. Cancer Cell (2010) 1.95
Srb10/Cdk8 regulates yeast filamentous growth by phosphorylating the transcription factor Ste12. Nature (2003) 1.92
The cyclin-dependent kinase 8 module sterically blocks Mediator interactions with RNA polymerase II. Proc Natl Acad Sci U S A (2006) 1.91
Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood (2005) 1.84
Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell (2004) 1.81
Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1. Mol Cell Biol (2006) 1.75
Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc Natl Acad Sci U S A (1995) 1.73
Notch signaling in solid tumors. Curr Top Dev Biol (2010) 1.66
Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma. Mol Cell Biol (1992) 1.62
Cyclin C/CDK8 is a novel CTD kinase associated with RNA polymerase II. Oncogene (1996) 1.58
Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J Exp Med (2008) 1.49
Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia. Clin Cancer Res (2007) 1.44
Physiological relevance of cell cycle kinases. Physiol Rev (2011) 1.44
Inactivation of LEF1 in T-cell acute lymphoblastic leukemia. Blood (2010) 1.40
Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II. Mol Biol Cell (1996) 1.35
Notch signaling: switching an oncogene to a tumor suppressor. Blood (2014) 1.32
T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene (1994) 1.25
Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol. J Clin Oncol (2009) 1.22
Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood (2007) 1.19
High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. Leukemia (2006) 1.14
A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene. Proc Natl Acad Sci U S A (2001) 1.13
A kinase subunit of the human mediator complex, CDK8, positively regulates transcriptional activation. Genes Cells (2007) 1.05
Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis. Cancer Res (2000) 1.05
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome. J Clin Pathol (2005) 1.02
A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer (2000) 1.02
Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors. Genomics (1996) 0.98
Dysregulation of CDK8 and Cyclin C in tumorigenesis. J Genet Genomics (2011) 0.97
Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression. Mol Cell Biol (2009) 0.96
A critical role for cyclin C in promotion of the hematopoietic cell cycle by cooperation with c-Myc. Mol Cell Biol (1998) 0.96
A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene. Cancer Res (2004) 0.94
Cyclin C regulates human hematopoietic stem/progenitor cell quiescence. Stem Cells (2010) 0.93
Allelic imbalance of chromosome 6q in ovarian tumours. Br J Cancer (1995) 0.92
Defining the region(s) of deletion at 6q16-q22 in human prostate cancer. Genes Chromosomes Cancer (2002) 0.90
Highly frequent allelic loss of chromosome 6q16-23 in osteosarcoma: involvement of cyclin C in osteosarcoma. Int J Mol Med (2006) 0.89
Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3. Jpn J Cancer Res (2000) 0.88
The prognostic value and overexpression of cyclin A is correlated with gene amplification of both cyclin A and cyclin E in breast cancer patient. Cell Oncol (2006) 0.84
Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphoma. Indian J Cancer (2007) 0.83
Cell cycle regulatory effects of retinoic Acid and forskolin are mediated by the cyclin C gene. J Mol Biol (2009) 0.80
Evaluation of malignant and benign gastric biopsy specimens by mRNA expression profile and multivariate statistical methods. Cytometry B Clin Cytom (2007) 0.79
Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature (2014) 1.81
Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature (2014) 1.65
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature (2017) 1.41
An ERK/Cdk5 axis controls the diabetogenic actions of PPARγ. Nature (2014) 1.29
Post-transcriptional regulation of meiotic genes by a nuclear RNA silencing complex. RNA (2014) 1.00
TIRR regulates 53BP1 by masking its histone methyl-lysine binding function. Nature (2017) 0.87
LIN28 phosphorylation by MAPK/ERK couples signalling to the post-transcriptional control of pluripotency. Nat Cell Biol (2016) 0.86
Proteome complexity and the forces that drive proteome imbalance. Nature (2016) 0.84
Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis. Nat Cell Biol (2015) 0.80
G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells. Nat Cell Biol (2017) 0.78
Plasmodium falciparum CRK4 directs continuous rounds of DNA replication during schizogony. Nat Microbiol (2017) 0.77
PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia. Nat Cell Biol (2016) 0.77
Architecture of the human interactome defines protein communities and disease networks. Nature (2017) 0.76
Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism. Nat Commun (2017) 0.75
Cell biology: balancing act. Nature (2014) 0.75
TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature (2017) 0.75
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature (2017) 0.75